Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Medite Cancer Diagnostics Inc (EM) MDIT

Healthcare Technology Medical Instruments & Supplies Scientific & Technical Instruments
Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under... see more

Current News (EXPM:MDIT)

MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director

GlobeNewswire November 15, 2017

MEDITE Cancer Diagnostics Reports 2017 Third Quarter Financial Results

GlobeNewswire November 14, 2017

MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer

GlobeNewswire November 8, 2017

MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results

Marketwired August 14, 2017

MEDITE Cancer Diagnostics to Launch SureCyte(TM) C1 Stain Globally at the 29th European Congress of Pathology

Marketwired July 27, 2017

MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations

Marketwired May 10, 2017

MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations

Marketwired April 28, 2017

MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer

Marketwired April 27, 2017

MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors

Marketwired March 7, 2017
View More News ››

Opinion & Analysis (EXPM:MDIT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:MDIT)

Be the first to post on this bullboard.

Algernon Health Inc.

Algernon Health Inc.

Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company ...
View More »

Podcasts